MedPath

Spinal Anaesthesia for lower abdominal and lower limb surgeries- Comparison of Heavy formulations of Levobupivacaine, ropivacaine with racemic bupivacaine

Not yet recruiting
Registration Number
CTRI/2023/02/049556
Lead Sponsor
Dr Juliet Ann Abraham
Brief Summary

Spinal Anaesthesia is the gold standard for infraumbilical surgeries. Commonly used as spinal anaesthetic is 0.5% Hyperbaric Bupivacaine in spite of their cardiotoxic and neurotoxic property, if intravascular access is gained. This is due to the R- enantiomer component which has increased affinity for the sodium channels in cardiac tissue. This led to the formulation of levobupivacaine and ropivacaine, pure S-enantiomers and long acting local anaesthetic agents. Until recently Hyperbaric solutions of levobupivacaine and ropivacaine were not available. Hence this study. It is a proposed randomised control trial, where the patients are counselled regarding the procedure and their consent is attained. They are divided into groups of three with 35 in each given and given their allocated drug. The different parameters studied are the onset and duration of motor and sensory blockade, post-operative analgesia, hemodynamic parameters and complications. The results are then tallied to compare the efficiency and safety profile of levobupivacaine and ropivacaine against racemic bupivacaine.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
105
Inclusion Criteria

ASA I-11 Age 20- 70 years Height 150-180cms Infraumbilical surgeries >2 hours.

Exclusion Criteria

Patient refusal Local infection Coagulopathies Allergy to the study drugs Any pre-existing neurological deficits Parturients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of onset and duration of motor blockadeThe onset of the maximum motor blockade- attaining Grade 4 on the Modified Bromage scale- checked every 3 mins from the time of administration (3 mins, 6 mins, 9 mins, 12 mins) | The duration of the motor blockade- from the onset of the motor blockade [(Grade 4 on Modified Bromage scale), peaking at (Modified Bromage scale Grade 1)]till the effect of the drug is completely subsided (Modified Bromage scale Grade 6) - checked every 20 mins post-surgery (20 mins, 40 mins, 60 mins..120mins )
Secondary Outcome Measures
NameTimeMethod
1. To compare the onset and duration of sensory blockadeThe onset of the sensory blockade - blockade at the level of T10 dermatome - checked every minute from the time of administration of the drug (1 min, 2 min, 3 min, 4 min, 5 min)
To compare the total consumption of rescue analgesia when the comparator agent and interventional agents are administeredThe total consumption of rescue analgesia is determined by the need for intravenous analgesics for the first 6 hours post-surgery (1st hour, 2nd hr...6th hour)
Comparison of intraoperative hemodynamic profile and occurrence of adverse effects with each study drugVitals are recorded every two minutes from the time of administration of the drug (0 min, 2 mins, 4 mins...) for the first 20 minutes and then every 5 minutes till the end of the surgical procedure.

Trial Locations

Locations (1)

MOSC Medical College Hospital

🇮🇳

Ernakulam, KERALA, India

MOSC Medical College Hospital
🇮🇳Ernakulam, KERALA, India
Dr Juliet Ann Abraham
Principal investigator
9188605017
juliet_ann19@ymail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.